{"disease":{"id":"treatment-of-adult-patients-with-locally-advanced-unresectable-stage-iii-nsclc-whose-disease-has-not-progressed-during-or-following-concurrent-or-sequential-platinum-based-chemoradiation-therapy-and-whose-tumors-have-egfr-exon-19-deletions-or-exon-21-l858r-mutations.md","name":"treatment of adult patients with locally advanced unresectable stage iii nsclc whose disease has not progressed during or following concurrent or sequential platinum based chemoradiation therapy and whose tumors have egfr exon 19 deletions or exon 21 l858r mutations.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}